0001209191-20-036360.txt : 20200612
0001209191-20-036360.hdr.sgml : 20200612
20200612173259
ACCESSION NUMBER: 0001209191-20-036360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200413
FILED AS OF DATE: 20200612
DATE AS OF CHANGE: 20200612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galante Joseph C
CENTRAL INDEX KEY: 0001632384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 20961222
MAIL ADDRESS:
STREET 1: 111 TENTH AVENUE
STREET 2: SUITE 200
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-13
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001632384
Galante Joseph C
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2020-04-13
4
P
0
75
4.03
A
17767
D
Common Stock
2020-04-15
4
P
0
150
4.05
A
17917
D
Common Stock
2020-04-17
4
P
0
150
4.04
A
18067
D
Common Stock
2020-04-21
4
P
0
150
4.03
A
18217
D
Common Stock
2020-04-23
4
P
0
150
4.03
A
18367
D
Common Stock
2020-04-27
4
P
0
150
4.02
A
18517
D
Common Stock
2020-04-29
4
P
0
150
4.01
A
18667
D
Common Stock
2020-05-01
4
P
0
150
4.01
A
18817
D
Common Stock
2020-05-05
4
P
0
150
3.99
A
18967
D
Common Stock
2020-05-07
4
P
0
150
3.97
A
19117
D
Common Stock
2020-05-11
4
P
0
150
4.02
A
19267
D
Common Stock
2020-05-13
4
P
0
150
3.93
A
19417
D
Common Stock
2020-05-14
4
P
0
75
3.81
A
19492
D
Common Stock
2020-05-15
4
P
0
75
3.76
A
19567
D
Common Stock
2020-05-18
4
P
0
75
3.82
A
19642
D
Common Stock
2020-05-19
4
P
0
75
3.78
A
19717
D
Common Stock
2020-05-20
4
P
0
75
3.77
A
19792
D
Common Stock
2020-05-21
4
P
0
75
3.68
A
19867
D
Common Stock
2020-05-22
4
P
0
75
3.61
A
19942
D
Common Stock
2020-05-26
4
P
0
75
3.59
A
20017
D
Common Stock
2020-05-27
4
P
0
75
3.49
A
20092
D
Common Stock
2020-05-28
4
P
0
75
3.34
A
20167
D
Common Stock
2020-05-29
4
P
0
75
3.35
A
20242
D
Common Stock
2020-06-01
4
P
0
75
3.45
A
20317
D
Common Stock
2020-06-02
4
P
0
75
3.35
A
20392
D
Common Stock
2020-06-03
4
P
0
75
3.29
A
20467
D
Common Stock
2020-06-04
4
P
0
75
3.31
A
20542
D
Common Stock
2020-06-05
4
P
0
75
3.44
A
20617
D
Common Stock
2020-06-08
4
P
0
75
3.54
A
20692
D
Common Stock
2020-06-09
4
P
0
75
3.48
A
20767
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020.
Joseph C. Galante by /s/ Michael Bonner as
attorney-in-fact
2020-06-12